Welcome to our dedicated page for Clorox Co Del SEC filings (Ticker: CLX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From the bleach that powers hospital disinfection to Hidden Valley salad dressing on kitchen tables, Clorox’s portfolio touches nearly every room of the home—and that breadth shows up in its SEC paperwork. The 10-K alone tracks raw-material inflation on sodium hypochlorite, charcoal volumes at Kingsford, and plastic-reduction targets across Brita and Glad. If you’ve ever searched Google for “Clorox SEC filings explained simply� or wondered where to locate a “Clorox insider trading Form 4 transactions� alert, you’re in the right place.
Stock Titan’s AI decodes each release the moment it hits EDGAR. Our real-time engine flags “Clorox Form 4 insider transactions real-time,� pulls margin commentary from every “Clorox quarterly earnings report 10-Q filing,� and distills risk-factor changes so you can grasp them in minutes. Need to understand the ESG footnotes? Click the “Clorox annual report 10-K simplified� summary. Curious about board pay? The platform links directly to the “Clorox proxy statement executive compensation� tables and highlights year-over-year shifts.
Investors use these insights to monitor bleach demand during flu season, compare segment profits between Household and Lifestyle units, and track “Clorox 8-K material events explained”—from factory outages to strategic divestitures. Whether you’re screening “Clorox earnings report filing analysis� for revenue trends or verifying “Clorox executive stock transactions Form 4� before making a move, Stock Titan equips you with AI-powered summaries, real-time filing updates, and comprehensive coverage of every form—saving you hours of document review.
The Clorox Company reported fiscal 2025 net sales of $7.1 billion and employed about 7,600 people worldwide. Net sales were essentially flat for the year while the company grew overall market share and expanded gross margin. Diluted net earnings per share rose 190%, driven largely by the absence of prior-period Argentina divestiture losses and a prior pension settlement charge, together with higher current‑period volume, cost savings and cyberattack insurance recoveries, partially offset by the loss on the divestiture of the Better Health VMS business, unfavorable mix and higher trade promotion spending.
Clorox completed the Better Health VMS divestiture in September 2024, is winding down the Glad venture with P&G (P&G’s 20% to be acquired by Clorox at fair market value upon termination), and continues a multi‑year transformational program including ERP and digital investments with total incremental spend expected to be $570�$580 million. The company paid $602 million in dividends in FY2025 and announced a 2% dividend increase in July 2025. Key concentrations and metrics disclosed include >80% of sales from brands ranking No.1 or No.2 in category, product-line mix (Cleaning 44%, Bags & Wraps 15%, Food 12%, Cat Litter 10%), and Walmart accounting for 27% of consolidated net sales.